DCPH
Deciphera Pharmaceuticals LLC
NASDAQ: DCPH · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$25.59
+0.00% today
Updated 2026-04-30
Market cap
$2.21B
P/E ratio
—
P/S ratio
12.65x
EPS (TTM)
$-2.21
Dividend yield
—
52W range
$0 – $0
Volume
0.0M
WallStSmart proprietary scores
30
out of 100
Grade: F
Strong Sell
Investment rating
8.0
Growth
A5.0
Quality
C+2.0
Profitability
F6.7
Valuation
B—/9
Piotroski F-Score
—
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →202 stocks currently score above 75
Price targets
Analyst target
$27.52
+7.54%
12-Month target
—
—
Intrinsic (DCF)
$53.59
Margin of safety
+52.25%
Price chart
X-Ray snapshot
Strengths
+ Revenue growth 34.50% QoQ
+ 52.25% below intrinsic value
Risks
- Thin margins at -108.90%
- Negative free cash flow $-54.73M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2020 | 2021 | 2022 | 2023 | TTM |
|---|---|---|---|---|---|
| Revenue | $42.09M | $96.15M | $134.04M | $163.36M | $174.91M |
| Net income | $-266.49M | $-296.84M | $-178.93M | $-194.94M | $-45.08M |
| EPS | — | — | — | — | $-2.21 |
| Free cash flow | $-245.00M | $-246.79M | $-153.70M | $-147.47M | $-54.73M |
| Profit margin | -633.19% | -308.73% | -133.49% | -119.34% | -108.90% |
Peer comparison
Smart narrative
Deciphera Pharmaceuticals LLC trades at $25.59. Our Smart Value Score of 30/100 indicates the stock is weak. TTM revenue stands at $174.91M. with profit margins at -108.90%. Our DCF model estimates intrinsic value at $53.59.
Frequently asked questions
What is Deciphera Pharmaceuticals LLC's stock price?
Deciphera Pharmaceuticals LLC (DCPH) trades at $25.59.
Is Deciphera Pharmaceuticals LLC overvalued?
Smart Value Score 30/100 (Grade F, Strong Sell). DCF value $53.59.
What is the price target of Deciphera Pharmaceuticals LLC (DCPH)?
The analyst target price is $27.52, representing +7.5% upside from the current price of $25.59.
What is the intrinsic value of Deciphera Pharmaceuticals LLC (DCPH)?
Based on our DCF model, intrinsic value is $53.59, a +52.3% margin of safety versus $25.59.
What is Deciphera Pharmaceuticals LLC's revenue?
TTM revenue is $174.91M.
Company info
SectorHEALTHCARE
IndustryDRUG MANUFACTURERS - SPECIALTY & GENERIC
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio12.65x
ROE-50.40%
Beta0.18
50D MA$21.67
200D MA$15.94
Shares out0.09B
Float0.05B
Short ratio—
Avg volume0.0M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—